














































We	 explored	 the	 hypothesis	 that	 increased	 cholinergic	 tone	 exerts	 its	 pro‐arrhythmic	45 




Electrophysiological	 studies	 in	 control	 patients	 with	 SVT	 only	 demonstrated	 shorter	50 
endocardial	 than	 epicardial	 right	 ventricular	 (RV)	 activation	 times	 (AT’s)	 (mean	51 
difference:	 26	ms,	 p<0.001).	 In	 contrast,	 BrS	 patients	 showed	 longer	 endocardial	 than	52 
epicardial	 AT	 (mean	 difference:	 ‐15	 ms,	 p=0.001).	 BrS	 hearts,	 compared	 to	 controls,	53 
showed	 significantly	 larger	 transmural	 gradients	 (TMG)	 in	 their	 activation	 recovery	54 
intervals	 (ARIs)	 (mean	 intervals	20.5	vs	3.5	ms;	p<0.01),	with	 longer	endocardial	 than	55 
epicardial	ARIs.	Edrophonium	challenge	increased	such	gradients	in	both	controls	(to	a	56 
mean	 of	 16	 msecs	 (p<0.001)	 and	 BrS	 (to	 29.7	 ms;	 p<0.001).	 However,	 these	 were	57 




















Brugada	Syndrome	 (BrS)	 remains	one	of	 the	most	 important	 causes	of	 sudden	cardiac	77 
death	 in	 the	 young,	 accounting	 for	 20%	 of	 such	 cases1.	 Its	 molecular	 basis	 remains	78 
uncertain.	Ion	channel	mutations	primarily	involving	the	sodium	channel	have	only	been	79 
identified	 in	 up	 to	 30%	 of	 subjects2.	 The	 pathophysiological	 basis	 for	 its	 associated	80 
arrhythmias	 also	 remains	 contentious.	 BrS	 is	 characterised	 by	 a	 triad	 of	 right	 bundle	81 
branch	 block	 (RBBB),	 coved	 ST	 elevation	 in	 the	 right	 precordial	 leads	 and	 lethal	82 
ventricular	arrhythmias.	The	disease	appears	localised	to	the	right	ventricle	(RV)	where	83 
dynamic	 changes	 in	 ST	 elevation	 and	 ventricular	 arrhythmias	 develop	 in	 situations	 of	84 
increased	vagal	tone.		85 
	86 
High	 density	 intra‐cardiac	mapping	 by	 our	 group	 has	 identified	 significant	 conduction	87 
delays	in	the	RV	outflow	tract	(RVOT)	compared	to	the	RV	body	and	apex	in	BrS	relative	88 
to	findings	in	control	patients3.	These	data	have	been	corroborated	and	it	is	now	evident	89 
that	 BrS	 is	 further	 associated	 with	 marked	 epicardial	 conduction	 abnormalities	 and	90 
increased	fibrosis4‐7.	Such	fibrotic	changes	could	lead	to	electrotonic	uncoupling	between	91 
myocytes	 with	 source:sink	 mismatches	 between	 endocardium	 and	 epicardium.	 These	92 
could	 produce	 the	 alterations	 in	 conduction	 or	 repolarisation	 gradients	 reported	 in	 a	93 
recent	 mechanistic	 human	 study8.	 BrS	 has	 a	 more	 common	 nocturnal	 occurrence	 of	94 
ventricular	 fibrillation	 which	 occurs	 in	 parallel	 with	 a	 corresponding	 nocturnal	95 
accentuation	 of	 its	 pathognomonic	 ECG	 features9.	 These	 in	 turn	 correspond	 to	 the	96 
increased	vagal	and	diminished	sympathetic	activity	during	periods	of	rest10.	However,	97 
the	 electrophysiological	 effects	 of	 changes	 in	 autonomic	 tone	 on	 the	 BrS	 substrate	98 
remain	uncertain.			99 
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Here	 we	 explore	 the	 hypothesis	 that	 in	 BrS	 such	 increased	 cholinergic	 tone	 induces	100 
conduction	 delay	 and	 promotes	 either	 intramural	 or	 transmural	 dispersions	 of	101 
repolarisation	 in	the	RVOT.	We	evaluated	the	effect	of	cholinergic	activation	on	 in	vivo	102 






The data, analytic methods, and study materials will be made available to other researchers for 108 




anti‐arrhythmic	 drugs	 had	 first	 been	 stopped	 for	 at	 least	 5	 half	 lives	 prior	 to	 the	113 
procedures.	 The	 detailed	 techniques	 for	 non‐contact	 mapping	 in	 the	 ventricle	 are	114 
described	 elsewhere12.	 The	 multi‐electrode	 array	 (MEA)	 (Ensite,	 St	 Jude	 Medical,	 St. 115 
Paul, Minnesota, USA)	was	deployed	via	 the	 left	 femoral	 vein	 in	 the	 right	ventricular	116 
outflow	 tract	 (RVOT)	 (full	 methodology	 described	 previously3).	 An	 epicardial	 16‐pole	117 





Programmed	 ventricular	 stimulation	 was	 performed	 from	 the	 right	 ventricular	 apex.	123 
Three	minutes	of	steady	state	pacing	at	a	coupling	interval	of	400	ms	was	followed	by	a	124 
S1S2	 restitution	 protocol	 using	 400	 ms	 drive	 trains.	 The	 extrastimulus	 was	 initially	125 
extended	 progressively	 by	 50	 ms	 intervals	 until	 consistent	 fusion	 with	 sinus	 beats	126 
occurred.	The	S1S2	interval	was	thereafter	decreased	at	20	ms	intervals	to	300	ms,	then	127 






obtain	 local	endocardial	data	within	3	cm	of	 the	array	directly	opposite	the	position	of	133 
the	 16	 pole	 Cardima	 catheter	 (Fig.	 1).	 Endocardial	 &	 epicardial	 electrograms	 were	134 
exported	and	analysed	using	semi‐automated	custom	software	 running	 in	Matlab	 (The	135 
Mathworks	 Inc.,	 MA,	 USA)	 (Figure	 S1).	 All	 electrograms	 and	 analyses	 were	 manually	136 





local	 AT.	 Two	 methods	 have	 been	 used	 to	 measure	 repolarisation	 times	 during	 non‐142 
contact	mapping,	 respectively	 termed	 the	classical	 (Wyatt)	method	and	 the	alternative	143 
method.	Both	have	come	under	 intense	theoretical	and	experimental	scrutiny;	here	we	144 
present	results	using	the	classical	method13‐16.	Activation	repolarisation	interval	(ARI),	a	145 
well‐validated	 approximation	 of	 action	 potential	 duration,	 was	 defined	 as	 the	 interval	146 
between	 the	 AT	 and	 repolarization	 time	 (Figure	 S1).	 The	 slope	 of	 ARI	 restitution	was	147 











isolated	 from	 peripheral	 blood	 leukocytes	 with	 the	 use	 of	 a	 commercial	 kit	 (Gentra	158 
System,	 Puregene).	 The	 exons	 of	 SCN5A	 were	 amplified	 and	 analyzed	 by	 direct	159 
sequencing.	 Polymerase	 chain	 reaction	products	were	purified	with	Exosap	 (USB)	 and	160 




All	statistical	computing	was	performed	using	R	software	(The Comprehensive R Archive 165 
Network (CRAN)). Continuous	 parametric	 data	 are	 presented	 as	 means	 ±	 standard	166 
deviations	(SD)	or,	in	the	case	of	significance	derived	from	regression	models,	mean	with	167 
[95%	 confidence	 interval],	 unless	 otherwise	 specified.	 Comparisons	 in	 which	 a	 single	168 
measurement	 was	 taken	 for	 each	 subject,	 e.g.	 ventricular	 effective	 refractory	 period	169 
(VERP),	 dispersion	 of	 repolarisation	 time,	were	made	using	 Student’s	 t‐test	with	 post‐170 
hoc	 correction	 for	 multiple	 comparisons.	 Continuous	 parametric	 data	 derived	 from	171 
electrogram	data	were	modelled	using	mixed‐effects	 linear	 regression (software: Linear 172 
and Nonlinear Mixed Effects (NLME) package running in R version 2.14)	 and	 statistical	173 
significance was inferred from the model. Quartile regression with bootstrapping (Quantile 174 








MRI	excluding	gadolinium	 late	 enhancement	or	T1	mapping	 abnormalities	 in	 the	 right	183 
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Genetic	 data	 are	 available	 in	 4	 subjects:	 BrS	 cases	 3‐5	 were	 negative	 for	 known	188 




The	 control	 group	 of	 patients	 had	 SVT.	 They	 had	 normal	 resting	 and	 signal	 averaged	193 
ECGs,	a	negative	ajmaline	challenge	test,	structurally	normal	hearts	on	echocardiography	194 
and	no	family	history	of	sudden	cardiac	death.	Informed	consent	was	obtained	following	195 








During	 steady	 pacing,	 epicardial	 activation	 times	 (ATs)	 and	 activation	 recovery	204 
intervals	 (ARIs)	were	 significantly	 shorter	 in	BrS	 than	 in	 control	 patients	 and	neither	205 
were	significantly	affected	by	edrophonium	challenge	(Fig.	S2).		In	contrast,	endocardial	206 
AT	 and	 ARI	 were	 significantly	 longer	 in	 BrS	 than	 control	 patients,	 and	 similarly	 only	207 
minimally	affected	by	edrophonium	challenge.		208 
Formatted: Font color: Red
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Measurements	made	through	varying	coupling	intervals	used	to	construct	restitution	209 
curves	demonstrated	 that	 control	patients	 showed	shorter	endocardial	 than	epicardial	210 
ATs	 that	 gave	 mean	 AT	 differences	 of	 26	 ms,	 95%	 CI:	 21,	 32	 for	 endocardium	 and	211 
epicardium	 respectively,	 p<0.001(Fig.	 2).	 In	 contrast,	 the	 BrS	 patients	 showed	 longer	212 
endocardial	 AT	 than	 epicardial	 AT	 (mean	 AT	 difference:	 15	 ms,	 95%	 CI	 11,	 20,	 for	213 
endocardium	and	epicardium	respectively;	p=0.001).	Following	edrophonium	challenge,	214 
both	 endocardial	 and	 epicardial	 ATs	 were	 unchanged	 in	 the	 control	 but	 significantly	215 
further	shortened	in	the	BrS	patients.	However,	neither	control	nor	BrS	patients	showed	216 
significant	changes	in	their	transmural	activation	time	differences.	When we measured the 217 
regional delay to assess conduction reserve, this was greater in the epicardium than 218 
endocardium in BrS versus controls and was further exaggerated following edrophonium (Fig 219 
S3).  220 
	221 
Hearts	 from	 the	control	patients	 showed	minimal	 transmural	gradients	 (TMG)	 in	 their	222 
ARIs	 (mean	 3.4	 ms,	 95%	 CI:	 6.8,	 0.02,	 p<0.05)	 with	 endocardial	 ARIs	 that	 were	223 
marginally	shorter	than	epicardial	ARIs	(Fig.	3).	In	contrast,	hearts	from	the	BrS	patients	224 
showed	 significantly	 larger	 TMG	 (mean	 20.5	 ms,	 95%	 CI:	 25.5,	 15.5,	 p<0.001),	 with	225 
shorter	epicardial	ARIs	than	endocardial	ARIs.	226 
Following	edrophonium	challenge,	the	TMG	in	hearts	from	control	patients	increased	to	227 
a	 mean	 of	 16	 ms	 (95%	 CI:	 19.6,	 12.6,	 p<0.001),	 and	 this	 reflected	 an	 epicardial	 ARI	228 
prolongation.	The	TMG	in	hearts	from	BrS	patients	increased	to	29.7	ms	(95%	CI:	35.3,	229 
24.1,	p<0.001),	but	this	reflected	endocardial	as	opposed	to	epicardial	ARI	prolongation.	230 
These	 effects	 were	 particularly	 evident	 from	 contact	 endocardial	 and	 epicardial	231 
electrogram	 recordings	 illustrating	 the	 unipolar	 electrogram	 morphologies	 in	 hearts	232 






ran	 from	 epi‐	 to	 endocardium.	 However,	 in	 the	 BrS	 patients,	 epicardial	 repolarisation	238 
was	 completed	 earlier	 than	 endocardial	 repolarisation	 and	 showed	 smaller	 values	 at	239 









of	 patients	with	 BrS	 (mean	 0.887,	 SEM	 0.065)	 compared	with	 control	 patients	 (mean	249 
0.728,	 SEM	 0.046)	 with	 no	 significant	 changes	 following	 edrophonium	 challenge.	 The	250 
values	of	 Smax	 in	 the	 anterior	RVOT	endocardium	were	 similar	 in	hearts	 from	BrS	 and	251 
control	patients,	and	showed	no	significant	changes	following	edrophonium	challenge.	In	252 












Our	 studies	 determined	 epicardial	 and	 endocardial	 activation	 times	 (AT),	 activation	264 
recovery	 intervals	 (ARI),	 and	 recovery	 times	 (RTs)	 in	 both	 control	 and	 BrS	 patients.	265 
From	 these	 we	 derived	 the	 corresponding	 transmural	 gradients	 in	 AT,	 ARI	 and	 RTs	266 
before	 and	 following	 autonomic	 edrophonium	 challenge	 and	 related	 these	 phenotypic	267 
characteristics	 to	 findings	 in	BrS	or	normal	patients.	We	observed	significant	effects	of	268 
both	 absolute	 and	 transmural	 differences	 between	 both	 conduction	 and	 repolarisation	269 









challenge	 upon	 conduction	 velocity	 and	 repolarisation	 which	 govern	 the	 transmural	279 
activation	sequence.	Thus,	prior	to	cholinergic	challenge,	 the	main	differences	between	280 
human	BrS	 and	 controls	 reflected	 epicardial	 differences	with	 the	BrS	 showing	 shorter	281 
ARI’s	 and	 the	 epicardium	 activating	 earlier	 than	 the	 endocardium.	 This	 parallels	 the	282 
findings	of	other	groups7,8,	20.	Indeed	the	largest	mean	ARI	gradient	at	rest	is	equivalent:	283 
20.5ms	 versus	 24ms	 in	 the	 Langendorrff	 study	 of	 a	 Brugada	 heart20.	 	 This	 causes	 a	284 
significant	 reversed	 repolarisation	 gradient	 to	 arise	 from	 endocardium	 to	 epicardium	285 
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which	 did	 not	 exist	 in	 controls.	 	 Increased	 cholinergic	 tone	 through	 edrophonium	286 







The	 findings	 may	 reflect	 a	 differential	 distribution	 of	 ion	 channels	 between	 the	294 
endocardium	 and	 epicardium21.	 Differences	 in	 sodium	 channel,	 calcium	 channel	 and	295 
potassium	 channel	 expression	 and	 differential	 regulation	 of	 currents	 by	 autonomic	296 
pathways	 are	 likely	 to	 account	 for	 the	 striking	 endo	 and	 epicardial	 differences.	 This	297 
indicates	a	 loss	of	endocardial	 	 to	epicardial	conduction	reserve	which	could	be	due	to	298 
abnormalities	 in	 the	Purkinje	network	preventing	rapid	endocardial	 tissue	recruitment	299 




and	 endocardium	 and	 suggests	 the	main	 cholinergic	 effects	 in	 BrS	 are	 exerted	 on	 the	304 
endocardial	ARI,	combined	with	conduction	delays	amplifying	transmural	repolarisation	305 
dynamic	differences	across	coupling	intervals.	The	marked	conduction	delays	especially	at	306 
short	 coupling	 intervals	 in	 these	 studies	 in	 conjunction	 with	 the	 shorter	 ARI’s	 in	 the	307 






These	 variously	 explain	 its	 coved	 ST	 elevation	 by	 delayed	 depolarisation	 from	 the	 RV	313 
body	 to	RVOT	or	 transmural	gradients	 in	repolarisation	secondary	 to	a	shortened	“dip	314 
and	 plateau”	 action	 potential	morphology	 in	 the	 epicardium.	 The	 present	 findings	 are	315 
consistent	with	a	combination	of	these	mechanisms.	This	would	be	compatible	with	the	316 
differential	conduction	delay	between	the	endocardium	and	epicardium	and	the	earlier	317 
epicardial	 repolarisation	 in	 BrS.	 Furthermore,	 changes	 in	 coupling	 interval	 modulate	318 
these	 features	 on	 a	 beat	 to	 beat	 basis,	 and	 this	 would	 promote	 the	 creation	 of	319 
endocardial‐epicardial	 repolarisation	 gradients	 and	 hence	 ST	 elevation	 in	 the	 right	320 
precordial	 leads	 with	 the	 gradients	 particularly	 in	 the	 presence	 of	 electrotonic	321 
uncoupling	promoted	by	structural	abnormalities23,24.		322 
	323 
The	 findings	 also	 have	 implications	 for	 electrocardiographic	 changes	 following	324 
conditions	of	increased	cholinergic	tone	in	BrS.	 	Thus,	increased	vagal	tone	is	known	to	325 
produce	dynamic	changes	in	J	point	elevation	and	ventricular	arrhythmia.	Nakazawa	et	326 
al.	 reported	 that	 high	 vagal	 tone	 and	 low	 sympathetic	 tone	 are	 specific	 properties	 of	327 
symptomatic	BrS	on	the	basis	of	heart	rate	variability	data	25.	Their	study	also	suggested	328 
these	 autonomic	 imbalances	were	 significant	 in	 the	 symptomatic	 group	but	 not	 in	 the	329 
asymptomatic	group.	Dynamic	changes	in	J	point	elevation	are	more	prominent	at	night	330 




transient	 during	 phase	 2	 of	 the	 action	 potential	 resulting	 in	 increased	 transmural	335 
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dispersion	of	repolarisation	and	phase	2	re‐entry27.	The	data	supporting	this	hypothesis	336 
has	 been	 derived	 from	 the	 canine	 RV	 wedge	 preparation	 of	 BrS	 employing	337 
pharmacological	manipulations	to	reproduce	the	Brugada	ECG.		338 






of	 the	 substrate	 	 so	 it	 is	 possible	 that	more	 severely	 diseased	 areas	were	not	 studied.	345 
Nevertheless,	 these	 findings	 indicate	 sufficient	 pathology	 was	 present	 to	 enable	346 
significant	 differences	 in	 conduction‐repolarisation	 dynamics	 to	 be	 identified.	 These	347 
findings	 provide	 evidence	 of	 conduction‐repolarisation	 abnormalities	 in	 BrS	 without	348 
events	 but	 the	 extent	 of	 such	 changes	 need	 to	 be	 explored	 in	more	 severely	 affected	349 
individuals	as	 there	 is	preliminary	evidence	 to	suggest	 that	such	cases	may	have	more	350 
marked	 conduction	 abnormalities	 using	 ECG	 Imaging28,29	 .	 Indeed	 the	 extent	 of	 these	351 
changes	could	be	used	as	a	risk	marker	for	lethal	arrhythmias.	352 
	353 
These	 data	 have	 important	 clinical	 implications	 with	 recent	 interest	 in	 epicardial	354 
substrate	 ablation	 to	 prevent	 VF	 in	BrS30,31.	 Ablation	 appears	 to	 normalise	 the	 resting	355 
ECG	and	prevent	dynamic	ST	elevation.	This	may	operate	by	homogenising	the	substrate	356 
such	 that	 endo	and	epicardial	gradients	 can	no	 longer	be	generated	 in	 the	RVOT.	This	357 
will	prevent	changes	in	cholinergic	tone	influencing	the	gradient	&	enabling	VF	initiation	358 
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Supplemental	 Figure	 S1	 .	 Example	 of	 semi‐automated	 AT,	 ARI	 and	 RT	
measurements	from	intracardiac	Non‐contact	unipolar	signals.	The	blue	interrupted	





Supplemental	Figure	S2.	A.	Baseline	Epicardial	 	 AT,	ARI	 and	RT	 in	 Controls	 and	BrS	
during	 steady	 state	 pacing	 at	 400ms.	 *P<0.05	 between	 control	 and	 BrS.	 B.	 Baseline	




Boxplots	 representing	 the	 mean	 increase	 delay	 (MID),	 endocardially	 (Endo)	 and	 epicardially	
(Epi),	 for	 both	 Control	 and	 Brugada	 subjects,	 before	 (Base)	 and	 after	 Edrophonium	 (Edr)	
administration.	 For	 the	 control	 group,	 a	 significant	 difference	 in	 the	MID	between	endocardial	
and	epicardial	regions	was	induced	by	drug	administration.	For	the	Brugada	group,	a	significant	
difference	was	already	present	at	baseline	and	was	further	exacerbated.	These	difference	were	
mainly	due	to	a	MID	prolongation	in	the	epicardium.	*P<0.05	**P<0.01	***P<0.001	
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